Organ Transplant Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - By Offering (Kits and Assays, Consumables, and Services), By Application (Donor Testing (Pre-transplantation testing (Histocompatibility Testing, Blood Profiling Testing, and Other Testing), Post-transplantation testing (Post-Infection Testing, Risk of Disorder Testing, and Other Testing)), Recipient Testing (Pre-transplantation testing (Histocompatibility Testing, Blood Profiling Testing, and Other Testing), Post-transplantation Testing (Post-Infection Testing, Risk of Disorder Testing, and Other Testing)), By Transplant Type (Solid Organ Transplant (Kidney, Liver, Lung, Pancreas, and Other Organs Transplant), Stem Cell Transplant), By Technology (Molecular Technologies (PCR, Sanger Sequencing, Next-Generation Sequencing (NGS), Other Molecular Technologies), Non-molecular Technologies (Serology, Flow Cytometry), Other Technologies), By End User (Hospitals and Transplant Centers, Academic and Research Institutions, Reference Laboratories, and Other End Users), and By Region and Competition

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Organ transplant diagnostics involves a range of medical tests and procedures that are used to assess the compatibility between a potential organ donor and recipient. It also evaluates the condition of the organ before and after the transplantation. Various kinds of test that are involved in diagnosis of organ transplantation include blood tests, cross-matching, imaging tests, biopsy, echocardiogram, pulmonary function tests, and endoscopy. According to the data from the Global Observatory on Donation and Transplantation of 2020, the United States has been ranked as the highest position accounting for almost 40,000 transplantations in a year, followed by China, Brazil, Spain, and India. Among various organ transplantations, heart transplant recipients may need to undergo more diagnostic tests than other transplant recipients because of the complexity of the heart and the potential for complications. Some of the diagnostic tests that may be required for heart transplant recipients include echocardiograms, electrocardiograms, and cardiac catheterization. The growing prevalence of various chronic diseases such as cardiovascular diseases, chronic respiratory diseases, musculoskeletal diseases, neurological disorders, and kidney diseases is expected to register a lucrative growth of the global organ transplant diagnostics market during the forecast period. Many diagnostic tests are required for carrying out the transplantations of vital organs in the body which is increasing the demand for diagnostics in the market. Furthermore, growing geriatric population across the world and the emergence of various diseases such as arthritis, dementia, osteoporosis, and chronic obstructive pulmonary disease (COPD) are associated with people in their elder age. Such factors are expected to propel the growth of the global organ transplant diagnostics market in the coming years.

Rising Prevalence of Chronic Diseases

Chronic diseases are severe health conditions which develop slowly and persist over an extended period. Some of the major risk factors which lead to the development of chronic sickness in people comprises of genetic disorders, physical inactivity, intake of unbalanced diet, consumption of alcohol, smoking cigarettes, and others. United States of America, Canada, Australia, United Kingdom, Japan, and Germany are some of the developing countries which account for the highest mortality rate related to chronic diseases across the world. Prolonged prevalence of chronic disease in the human body which cannot be cured through medication require organ transplantations. According to Global Observatory on Donation and Transplantation (GODT) reported that globally around 139,347 organ transplantations were performed in 2019, followed by 144,302 organ transplantations performed across the world in 2021 with an increase of 11.3% from 2020. As per the report published by Health Resources & Services Administration (HSRA), it has been concluded that around 25,499 kidney transplantations were performed in 2022, followed by 9,528 liver transplantations, 4,111 heart transplantations, and 2,692 lung transplantations across the world. To perform transplantation of vital organs, various diagnostics tests are required to be carried out with the patient. For instance, several tests such as blood tests, urine tests, imaging tests, and biopsy are performed with the patient before kidney transplantations. Therefore, the growing demand for tests required for organ transplantations associated with the growing severity of chronic diseases are expected to register an impressive growth of the global organ transplant diagnostics market during the forecast period.

Increase in Geriatric Population

The rising prevalence of diseases among geriatric people which require organ transplantation for proper management of that disease is also expected to register a lucrative growth of the global organ transplant diagnostics market in the futuristic period. According to the United Network for Organ Sharing (UNOS), kidney transplantations is the most common type of organ transplantation performed among people above 65 years of age. According to data from the Organ Procurement and Transplantation Network (OPTN), in 2020, there were a total of 39,035 kidney transplants performed in the United States. Of these, 5,819 (14.9%) were performed in recipients who were 65 years of age or older. Another common transplantation which is performed among elderly people is liver transplant. According to data from the United Network for Organ Sharing (UNOS), the number of liver transplants performed in patients aged 65 years and older has been steadily increasing over the past decade. In 2020, there were a total of 2,651 liver transplants performed in patients aged 65 years and older in the United States, which represents approximately 25% of all liver transplants performed that year. Growing incidences of major organ transplants in people are increasing the demand for diagnostics across the world, which is further expected to propel the growth of the market in coming years.


Download Free Sample Report

Recent Developments

  • In January 2022, Hoffmann-LA Roche Ltd. unveiled Cobas Infinity edge, a cloud-based point-of-care platform that is available everywhere. Practitioners in the healthcare industry can manage patient data due to advanced technology. This has aided the business in diversifying its product offering.
  • In January 2019, Core Diagnostics launched its division for advanced diagnostic centers in nephrology called ‘nephroCORE’. These services will ensure the best clinical intervention to improve outcomes in several chronic and generic kidney diseases, including kidney transplants.
  • In August 2019, Care Dx (United States) acquired XynManagement (United States) to simplify transplant quality tracking and waitlist management.
  • In February 2019, Care Dx (United States) launched the Allosure for lung transplants.
  • In March 2022, Immucor, Inc., a company focused on transfusion and transplantation diagnostics, announced two additions to its transplant diagnostics portfolio, demonstrating its ongoing commitment to new advancements in the field of histocompatibility.
  • In March 2022, Biocartis and Ophiomics entered into a collaboration to focus on the commercialization of HepatoPredict, a prognostic gene expression signature test to identify which patients will benefit from liver transplantation.
  • In August 2022, QIAGEN announced the publication in the Journal of Molecular Pathology of an externally facilitated clinical NGS interpretation validation study, demonstrating that its clinical decision support software, QIAGEN Clinical Insight Interpret One (QCI Interpret One), achieved a higher level of concordance with a panel of experts than human reviewers achieved among each other. The study commissioned by QDI and carried out independently by Genomics Quality Assessment (GenQA) investigated the classification of variants reported from oncology patient samples. This has helped the company to validate its research.
  • In April 2023, bioMérieux S.A. and Oxford Nanopore entered into a strategic partnership agreement to develop innovative infectious disease diagnostics, which would also lead to the development of infectious disease tests used during transplantation.
  • In April 2023, CareDx and Miromatrix announced an exclusive partnership to advance research using bioengineered organs for human transplantation.
  • In November 2022, Bio-Rad Laboratories and NuProbe USA signed a licensing agreement for digital PCR assay development. The technology would advance Bio-Rad’s portfolio.
  • In October 2022, Eurobio Scientific finalized the purchase of a 100% stake in Genome Diagnostics BV (GenDx) in a deal valued at $132.3 million.
  • In September 2022, BioMAdvanced Diagnostics announced fundraising of $1.3 million. The fundraising would allow BioMAdvanced Diagnostics to finalize the design of its first products and to start two clinical studies, one on the rejection of kidney transplants and the other on the lung.
  • In September 2022, GenDx announced that it had signed a non-exclusive service agreement with Oxford Nanopore Technologies (Oxford Nanopore) to bring its new NGS-Turbo product to the transplant market for high-resolution HLA typing.

Market Segmentation

The global organ transplant diagnostics market is segmented based on offering, application, transplant type, technology, end user, and region. In terms of offering, the global organ transplant diagnostics market is categorized into kits and assays, consumables, and services. Based on application, the global organ transplant diagnostics market is fragmented into donor testing (pre-transplantation testing (histocompatibility testing, blood profiling testing, and other testing), post-transplantation testing (post-infection testing, risk of disorder testing, and other testing)), recipient testing (pre-transplantation testing (histocompatibility testing, blood profiling testing, and other testing), post-transplantation testing (post-infection testing, risk of disorder testing, and other testing). Based on transplant type, the market is segmented into solid organ transplant (kidney, liver, lung, pancreas, other organs transplant), and stem cell transplant. Based on technology, the market is fragmented into molecular technologies (PCR, sanger sequencing, next-generation sequencing (NGS), and other molecular technologies), non-molecular technologies (serology, flow cytometry), and other technologies. Based on end user, the market is categorized into hospitals and transplant centers, academic and research institutions, reference laboratories, and other end users.

Market Players

Abbott Laboratories, bioMérieux S.A., Bio-Rad Laboratories, Inc., Eurobio Scientific (Genome Diagnostics B.V.), F. Hoffmann-La Roche Ltd., Omixon Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, CareDx, Inc., and Core Diagnostics Private Limited are some of the key players in the global organ transplant diagnostics market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, Volume in tons and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, Volume forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Offering

·         Application

·         Transplant Type

·         Technology

·         End User

Regional scope

North America; Asia Pacific; Europe; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia;

Key companies profiled

Abbott Laboratories, bioMérieux S.A., Bio-Rad Laboratories, Inc., Eurobio Scientific (Genome Diagnostics B.V.), F. Hoffmann-La Roche Ltd., Omixon Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, CareDx, Inc., Core Diagnostics Private Limited

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, the global organ transplant diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Organ Transplant Diagnostics Market, By Offering:

o    Kits and Assays

o    Consumables

o    Services

  • Organ Transplant Diagnostics Market, By Application:

o    Donor Testing (Pre-transplantation testing (Histocompatibility Testing, Blood Profiling Testing, Other Testing), Post-transplantation testing (Post-Infection Testing, Risk of Disorder Testing, Other Testing))

o    Recipient Testing (Pre-transplantation testing (Histocompatibility Testing, Blood Profiling Testing, Other Testing), Post-transplantation Testing (Post-Infection Testing, Risk of Disorder Testing, Other Testing)

  • Organ Transplant Diagnostics Market, By Transplant Type:

o    Solid Organ Transplant (Kidney, Liver, Lung, Pancreas, Other Organs Transplant)

o    Stem Cell Transplant

  • Organ Transplant Diagnostics Market, By Technology:

o    Molecular Technologies (PCR, Sanger Sequencing, Next-Generation Sequencing (NGS), Other Molecular Technologies)

o    Non-molecular Technologies (Serology, Flow Cytometry)

o    Other Technologies

  • Organ Transplant Diagnostics Market, By End User:

o    Hospitals and Transplant Centers

o    Academic and Research Institutions

o    Reference Laboratories

o    Other End Users

  • Global Organ Transplant Diagnostics Market, By region:
    • North America
      • United States
      • Canada
      • Mexico
    • Asia-Pacific
      • China
      • India
      • South Korea
      • Australia
      • Japan
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global organ transplant diagnostics market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global organ transplant diagnostics market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Organ Transplant Diagnostics Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value & Volume

5.2.  Market Share & Forecast

5.2.1.    By Offering (Kits and Assays, Consumables, Services)

5.2.2.    By Application (Donor Testing (Pre-transplantation testing (Histocompatibility Testing, Blood Profiling Testing, Other Testing), Post-transplantation testing (Post-Infection Testing, Risk of Disorder Testing, Other Testing)), Recipient Testing (Pre-transplantation testing (Histocompatibility Testing, Blood Profiling Testing, Other Testing), Post-transplantation Testing (Post-Infection Testing, Risk of Disorder Testing, Other Testing))

5.2.3.    By Transplant Type (Solid Organ Transplant (Kidney, Liver, Lung, Pancreas, Other Organs Transplant), Stem Cell Transplant)

5.2.4.    By Technology (Molecular Technologies (PCR, Sanger Sequencing, Next-Generation Sequencing (NGS), Other Molecular Technologies), Non-molecular Technologies (Serology, Flow Cytometry), Other Technologies)

5.2.5.    By End User (Hospitals and Transplant Centers, Academic and Research Institutions, Reference Laboratories, Other End Users)

5.2.6.    By Region

5.2.7.    By Company (2022)

5.3.  Product Market Map 

6.    North America Organ Transplant Diagnostics Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value & Volume

6.2.  Market Share & Forecast

6.2.1.    By Offering

6.2.2.    By Application

6.2.3.    By Transplant Type

6.2.4.    By Technology

6.2.5.    By End User

6.2.6.    By Country

6.3.  North America: Country Analysis

6.3.1.    United States Organ Transplant Diagnostics Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.            By Value & Volume

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.            By Offering

6.3.1.2.2.            By Application

6.3.1.2.3.            By Transplant Type

6.3.1.2.4.            By Technology

6.3.1.2.5.            By End User

6.3.2.    Mexico Organ Transplant Diagnostics Market Outlook

6.3.2.1.            Market Size & Forecast

6.3.2.1.1.         By Value & Volume

6.3.2.2.            Market Share & Forecast

6.3.2.2.1.         By Offering

6.3.2.2.2. By Application

6.3.2.2.3. By Transplant Type

6.3.2.2.4. By Technology

6.3.2.2.5. By End User

6.3.3.    Canada Organ Transplant Diagnostics Market Outlook

6.3.3.1.            Market Size & Forecast

6.3.3.1.1.         By Value & Volume

6.3.3.2.            Market Share & Forecast

6.3.3.2.1.         By Offering

6.3.3.2.2. By Application

6.3.3.2.3. By Transplant Type

6.3.3.2.4. By Technology

6.3.3.2.5. By End User

7.    Europe Organ Transplant Diagnostics Market Outlook

7.1.  Market Size & Forecast

7.1.1.    By Value & Volume

7.2.  Market Share & Forecast

7.2.1.    By Offering

7.2.2.    By Application

7.2.3.    By Transplant Type

7.2.4.    By Technology

7.2.5.    By End User

7.2.6.    By Country

7.3   Europe: Country Analysis

7.3.1.   France Organ Transplant Diagnostics Market Outlook

7.3.1.1.            Market Size & Forecast

7.3.1.1.1.         By Value & Volume

7.3.1.2.            Market Share & Forecast

7.3.1.2.1.         By Offering

7.3.1.2.2. By Application

7.3.1.2.3. By Transplant Type

7.3.1.2.4. By Technology

7.3.1.2.5. By End User

7.3.2.   Germany Organ Transplant Diagnostics Market Outlook

7.3.2.1.            Market Size & Forecast

7.3.2.1.1.         By Value & Volume

7.3.2.2.            Market Share & Forecast

7.3.2.2.1.         By Offering

7.3.2.2.2. By Application

7.3.2.2.3. By Transplant Type

7.3.2.2.4. By Technology

7.3.2.2.5. By End User

7.3.3.   United Kingdom Organ Transplant Diagnostics Market Outlook

7.3.3.1.            Market Size & Forecast

7.3.3.1.1.         By Value & Volume

7.3.3.2.            Market Share & Forecast

7.3.3.2.1.         By Offering

7.3.3.2.2. By Application

7.3.3.2.3. By Transplant Type

7.3.3.2.4. By Technology

7.3.3.2.5. By End User

7.3.4.   Italy Organ Transplant Diagnostics Market Outlook

7.3.4.1.            Market Size & Forecast

7.3.4.1.1.         By Value & Volume

7.3.4.2.            Market Share & Forecast

7.3.4.2.1.         By Offering

7.3.4.2.2. By Application

7.3.4.2.3. By Transplant Type

7.3.4.2.4. By Technology

7.3.4.2.5. By End User

7.3.5.   Spain Organ Transplant Diagnostics Market Outlook

7.3.5.1.            Market Size & Forecast

7.3.5.1.1.         By Value & Volume

7.3.5.2.            Market Share & Forecast

7.3.5.2.1.         By Offering

7.3.5.2.2. By Application

7.3.5.2.3. By Transplant Type

7.3.5.2.4. By Technology

7.3.5.2.5. By End User

8.    Asia-Pacific Organ Transplant Diagnostics Market Outlook

8.1.  Market Size & Forecast        

8.1.1.    By Value & Volume

8.2.  Market Share & Forecast

8.2.1.    By Offering

8.2.2.    By Application

8.2.3.    By Transplant Type

8.2.4.    By Technology

8.2.5.    By End User

8.2.6.    By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.    China Organ Transplant Diagnostics Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.            By Value & Volume

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.            By Offering

8.3.1.2.2.            By Application

8.3.1.2.3.            By Transplant Type

8.3.1.2.4.            By Technology

8.3.1.2.5.            By End User

8.3.2.    India Organ Transplant Diagnostics Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.            By Value & Volume

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.            By Offering

8.3.2.2.2.            By Application

8.3.2.2.3.            By Transplant Type

8.3.2.2.4.            By Technology

8.3.2.2.5.            By End User

8.3.3.    South Korea Organ Transplant Diagnostics Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.            By Value & Volume

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.            By Offering

8.3.3.2.2.            By Application

8.3.3.2.3.            By Transplant Type

8.3.3.2.4.            By Technology

8.3.3.2.5.            By End User

8.3.4.    Japan Organ Transplant Diagnostics Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.            By Value & Volume

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.            By Offering

8.3.4.2.2.            By Application

8.3.4.2.3.            By Transplant Type

8.3.4.2.4.            By Technology

8.3.4.2.5.            By End User

8.3.5.    Australia Organ Transplant Diagnostics Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.            By Value & Volume

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.            By Offering

8.3.5.2.2.            By Application

8.3.5.2.3.            By Transplant Type

8.3.5.2.4.            By Technology

8.3.5.2.5.            By End User

9.    South America Organ Transplant Diagnostics Market Outlook

9.1.  Market Size & Forecast        

9.1.1.    By Value & Volume

9.2.  Market Share & Forecast

9.2.1.    By Offering

9.2.2.    By Application

9.2.3.    By Transplant Type

9.2.4.    By Technology

9.2.5.    By End User

9.2.6.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil Organ Transplant Diagnostics Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.            By Value & Volume

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.            By Offering

9.3.1.2.2.            By Application

9.3.1.2.3.            By Transplant Type

9.3.1.2.4.            By Technology

9.3.1.2.5.            By End User

9.3.2.    Argentina Organ Transplant Diagnostics Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.            By Value & Volume

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.            By Offering

9.3.2.2.2.            By Application

9.3.2.2.3.            By Transplant Type

9.3.2.2.4.            By Technology

9.3.2.2.5.            By End User

9.3.3.    Colombia Organ Transplant Diagnostics Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.            By Value & Volume

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.            By Offering

9.3.3.2.2.            By Application

9.3.3.2.3.            By Transplant Type

9.3.3.2.4.            By Technology

9.3.3.2.5.            By End User

10.  Middle East and Africa Organ Transplant Diagnostics Market Outlook

10.1.             Market Size & Forecast         

10.1.1. By Value & Volume

10.2.             Market Share & Forecast

10.2.1. By Offering

10.2.2. By Application

10.2.3. By Transplant Type

10.2.4. By Technology

10.2.5. By End User

10.2.6. By Country

10.3.             MEA: Country Analysis

10.3.1. South Africa Organ Transplant Diagnostics Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value & Volume

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Offering

10.3.1.2.2.         By Application

10.3.1.2.3.         By Transplant Type

10.3.1.2.4.         By Technology

10.3.1.2.5.         By End User

10.3.2. Saudi Arabia Organ Transplant Diagnostics Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value & Volume

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Offering

10.3.2.2.2.         By Application

10.3.2.2.3.         By Transplant Type

10.3.2.2.4.         By Technology

10.3.2.2.5.         By End User

10.3.3. UAE Organ Transplant Diagnostics Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value & Volume

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Offering

10.3.3.2.2.         By Application

10.3.3.2.3.         By Transplant Type

10.3.3.2.4.         By Technology

10.3.3.2.5.         By End User

11.  Market Dynamics

11.1.             Drivers

11.2.             Challenges

12.  Market Trends & Developments

13.  PESTLE Analysis

14.  Porter’s Five Forces Analysis

14.1.             Competition in the Industry

14.2.             Potential of New Entrants

14.3.             Power of Suppliers

14.4.             Power of Customers

14.5.             Threat of Substitute Product

15.  Competitive Landscape 

15.1.             Business Overview

15.2.             Company Snapshot

15.3.             Products & Services

15.4.             Financials (In case of listed companies)

15.5.             Recent Developments

15.6.             SWOT Analysis

15.6.1. Abbott Laboratories

15.6.2. bioMérieux S.A.  

15.6.3. Bio-Rad Laboratories, Inc.

15.6.4. Eurobio Scientific (Genome Diagnostics B.V.)

15.6.5. F. Hoffmann-La Roche Ltd.

15.6.6. Omixon Inc.

15.6.7. Thermo Fisher Scientific Inc.

15.6.8. Quest Diagnostics Incorporated

15.6.9. CareDx, Inc.

15.6.10.               Core Diagnostics Private Limited

16.  Strategic Recommendations

17.  About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

Growing prevalence of chronic diseases across the world which is increasing the demand for organ transplantation among people are driving the growth of the global organ transplant diagnostics market.

down-arrow

Abbott Laboratories, bioMérieux S.A., Bio-Rad Laboratories, Inc., Eurobio Scientific (Genome Diagnostics B.V.), F. Hoffmann-La Roche Ltd., Omixon Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, CareDx, Inc., Core Diagnostics Private Limited are some of the key players operating in the global organ transplant diagnostics market.

down-arrow

Growing geriatric population and emergence of certain diseases which are associated with them in their elder age are affecting the growth of the global organ transplant diagnostics market.

down-arrow

Based on transplant type, the solid organ transplant segment is dominating the market and is expected to maintain its dominance over the next five years owing to the occurrence of less bleeding after the transplantation and minimal risk factors associated with the organ transplant procedure.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Organ Transplant Diagnostics Market to be Dominated by Increasing Number of Organ Donors Across The World through 2028

Aug, 2023

Growing technological advancements in transplant technology and growing public awareness about organ donation and transplantation are the major drivers of the global organ transplant diagnostics mark

Why Choose Us